tiprankstipranks
Trending News
More News >
HAVN Life Sciences (HAVLF)
OTHER OTC:HAVLF
US Market

HAVN Life Sciences (HAVLF) Income Statement

Compare
32 Followers

HAVN Life Sciences Income Statement

Last quarter (Q3 2022), HAVN Life Sciences's total revenue was C$-12.06K, a decrease of -152.38% from the same quarter last year. In Q3, HAVN Life Sciences's net income was C$-632.69K. See HAVN Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 21Dec 19
Total Revenue
C$ 276.47KC$ 0.00C$ 0.00
Gross Profit
C$ 89.69KC$ -4.60MC$ 0.00
Operating Expenses
C$ 9.90MC$ 25.75MC$ 41.12K
Depreciation and Amortization
C$ 575.62KC$ 4.58MC$ 171.86K
EBITDA
C$ -21.80MC$ -25.76MC$ -40.58K
Operating Income
C$ -9.81MC$ -30.35MC$ -40.58K
Other Income/Expenses
C$ -12.63MC$ -27.49KC$ -446.34K
Pretax Income
C$ -22.44MC$ -30.38MC$ -40.58K
Net Income
C$ -22.44MC$ -30.38MC$ -40.58K
Per Share Metrics
Basic EPS
C$ -5.25C$ -8.47C$ -0.39
Diluted EPS
C$ -5.25C$ -8.47C$ -0.39
Weighted Average Shares Outstanding
4.28M 3.59M 104.05K
Weighted Average Shares Outstanding (Diluted)
4.28M 3.59M 104.05K
Currency in CAD

HAVN Life Sciences Earnings and Revenue History